Life Sciences
This separately managed account program is a joint venture between ELCO Management Co., LLC (ELCO) and LifeSci Partners. It is a proprietary investment strategy in which LifeSci Partners is the subadvisor and ELCO the manager.
ELCO leverages the significant scientific and investment success of portfolio manager, Mark Charest, PhD, LifeSci Partners, a global biotech/healthcare advisory firm, sourcing investments in breakthrough health and life science companies. ELCO Life Sciences separately managed account program plans to invest in small, mid, and large cap biotech, pharmaceutical, healthcare and life science companies addressing areas of high unmet medical need.
The objective is to generate above average long-term capital appreciation. The combination of LifeSci’s medical and scientific research, coupled with their investment experience, provides investors a differentiated perspective to investing in this space.